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Objective
To evaluate the role of diffuse myocardial fibrosis
(DMF) in familial Dilated Cardiomyopathy (fDCM)
using Equilibrium Contrast-CMR (EQ-CMR).
Background
Post mortem/biopsy studies have shown that DMF
occurs in DCM, but its clinical significance remains lar-
gely unknown as its assessment requires invasive biopsy.
EQ-CMR is a recently described technique that permits
the non-invasive and accurate assessment of DMF by
measuring the myocardial contrast volume of distribu-
tion (Vd(m)) at equilibrium contrast [1].
Methods
Using international diagnostic guidelines we identified
28 patients with fDCM (mean age 42, 61% male, 89%
NYHA class I, 11% NYHA class II). This cohort
excluded the most severe cases of fDCM due to the
high prevalence of permanent pacemakers or ICDs.
The Vd(m) (a measure of DMF) was compared to that
obtained in healthy volunteers (mean age 35, 63% male)
and also to other indexed CMR parameters, including
left atrial area and echocardiographic parameters of dia-
stolic function (tissue doppler and strain imaging).
Results
fDCM patients had increased LV size (95mls/m2 vs
73mls/m2 , p=0.0001), worse ejection fraction (55% vs
69%, p<0.0001), increased indexed left atrial area (LAAi)
(12.3cm2/m2 vs 9.5cm2/m2, p=0.0004) when compared
to healthy volunteers. Significantly impaired diastolic
function was detected in 14% of fDCM patients. No
patients had worse than mild mitral regurgitation.
The Vd(m) in patients was significantly greater than
that of healthy volunteers (Fig 1) (0.282 vs 0.234,
p=0.003). Vd(m) correlated with LAAi (fig 2) (r2= 0.44,
p<0.0001) and EF (r2=0.12, p=0.034), but was indepen-
dent of indexed LV diastolic volume, mass and echocar-
diographic derived parameters of diastolic function.
On univariate analysis, LAAi was predicted by both
Vd(m) (r2= 0.44) and E/Ea (r2= 0.31), which on multi-
variate analysis were independent with Vd(m) being the
strongest predictor.
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EQ-CMR can reliably and non-invasively measure
increased Vd(m), reflecting DMF even in patients with
mild fDCM. Diffuse myocardial fibrosis in this tightly
defined fDCM cohort correlates with known prognostic
variables, particularly LA size and EF. For LA size, DMF
is independent of diastolic function and the most impor-
tant predictor. As such, these data suggest EQ-CMR is
measuring a key disease parameter. Further study is
recommended.
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